方法：采用6个心理量表对46例UAP患者和46例健康人进行评定，并测定ADP诱导的血小板聚集率。
Methods:Forty-six UAP patients and 46 healthy subjects were evaluated with 6 psychological scales, and their adenosine diphosphate(ADP)-induced platelet aggregation function was determined.
目的：研究养血清脑颗粒治疗紧张性头痛的疗效，探讨其对血小板聚集率的影响及紧张性头痛可能的发病机制。
OBJECTIVE:To study the efficiency of yangxueqingnao granula on the treatment of tension headache and explore its effect on platelet aggregation rate as well as pathogenesy of tension headache.
结论金特佳对老年慢性肾功能衰竭患者具有降低血黏度和血小板最大聚集率及改善肾功能的作用。
Conclusion Jintejia is of benefit in lowering blood viscosity and improving renal function in senile patients with chronic renal failure.
方法选取接受阿司匹林治疗的患者302例。根据血小板聚集率筛选阿司匹林抵抗患者。
Methods 302 cases treated with aspirin were selected according to platelet aggregation rate, who were divided by washing methods.
大鼠血栓湿重降低；抑制兔血小板的聚集率。
It also decreased the rats' thrombosis and inhibited the rabbits' platelet aggregation rate.
血流变学改变、红细胞串珠样改变、红细胞膜变形性减低、血小板聚集率增高，血浆粘度及流动栓子增多是脑梗死发病的重要病理基础。
The change of membrane mobility, the raising of platelet assemble rate, the in creasing of plasma viscosity and flowing embolismare the important pathological basis of cerebral infarction .
结论通心络可以降低血小板聚集率，对于阿司匹林抵抗患者，选用通心络治疗可以取得一定的疗效。
Conclusion Tongxinluo may reduce platelet aggregation rate and produce certain therapeutic effect for the patients with aspirin resistance.
血小板聚集率是反映血小板聚集功能的重要指标。
Platelet aggregometry is an important reaction to platelet aggregation.
方法：采用全蝎提取液给家兔、小鼠静脉注射，并测定其血小板最大聚集率、血栓重量、纤维蛋白原含量及优球蛋白溶解时间的变化。
Methods: the changing of platelet aggregation rate, the thrombus weight, the content of fibrinogen and the euglobulin lysis time were determined after SEF iv on rabbit and mice.
观察20例急性脑梗塞，30例冠心病在微循环中微血栓的变化，同时检测血小板聚集率、D-2聚体。
The microthrombi, D- Dimer and platelet aggregation rate were observed in 30 patients with coronary heart disease and 20 patients with acute cerebral infarction.
无论二磷酸腺苷(adp)还是凝血酶作诱导剂时，染色和未染色血小板之间的最大聚集率均无差异。
The maximum aggregation rate between dyed and non dyed platelets was not significantly different in use of ADP or thrombin.
麦贞花颗粒组血GMP 140、血小板最大聚集率、D 二聚体的各项指标较治疗前均有明显下降，且优于对照组（P <0 .0 5 ，P <0 .0 1）。
The various indexes of blood GMP-140, maximum aggregation rate of blood platelet and D-dimer dropped markedly, with great difference from the control group (P<0.05, P<0.01).
目的：观察水蛭免加热提取物对鞣花酸所致高凝动物模型凝血系统及血小板聚集率的影响。
Objective: To observe the effect of non-heating leech extract on coagulation system and platelet aggregation in the model of blood hypercoagulable state induced by ellagic acid in mice and rats.
急性血淤模型大鼠服用复方血栓通滴丸，对模型大鼠血小板最大聚集百分率有一定的抑制作用。
The maximum percentage of platelet aggregation was significantly inhibited after treatment with compound Xueshuantong dripping-pill.
目的比较冠状动脉内与静脉应用替罗非班对急性冠状动脉综合征(ACS)患者冠状动脉和静脉内血小板聚集率(par)的影响。
Objective To investigate the effects of intracoronary and intravenous application of tirofiban on platelet aggregation rate (PAR) in patients with acute coronary syndrome (ACS).
结果超高倍显微镜直视法检查缺血性脑血管病患者的血小板聚集异常率为88.4%，红细胞聚集异常率为83.0%，红细胞流动性异常率为84.8%；
Results The abnormal rates of PLT clustering , RBC clustering, and RBC fluidity in patients with ICVD were 88.4% , 83.0% , and 84.8%, respectively .
目的探讨血小板聚集率及颈内动脉狭窄与脑梗塞发病的关系。
Objective To observe relationship between platelet aggregation rate, internal carotid artery stenosis and occurrence of cerebral infarction.
目的探讨脑梗死急性期血小板GMP- 140、血浆GMP - 140、血小板粘附率和聚集率的变化及意义。
Objective To explore the changes and significances of platelet granule membrane protein-140 (GMP-140), GMP-140 in plasma, PAdT and PAgT in patients with acute cerebral infarction.
目的探讨脑梗死急性期血小板GMP- 140、血浆GMP - 140、血小板粘附率和聚集率的变化及意义。
Objective To explore the changes and significances of platelet granule membrane protein-140 (GMP-140), GMP-140 in plasma, PAdT and PAgT in patients with acute cerebral infarction.
应用推荐